Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
O.k thanks for your replys, I feel the same and hope for the best thanks and good luck.
Thanks for the reply`s, and Im in neck deep at 1.72 but what really kills me is, If this stock was such a homerun why in the world would it be at eighty cents after this decent settlement/potentially partnership deal. You think everyone and there mother would have said hey this litigation is over and we know the science is great and now its only a matter of time before its a good stock. Lets grab all we can, and im not talking retail buys,im talking fund managers, and everyone in the know on wall street ? You think it would have been a buy frenzy after the end of the litigation Am I missing something here. Sorry if I sound negative but Im alittle dissappointed since I have a small fortune invested, either way Im going to ride this wave out and hope for the best. How much worse can it get ????? "RIGHT LONGS"
Can it be said with the litigation over, the longs on this board posting pages of positive information about the science for the last couple of years feel 100 % sure of the company future sucess. After all the science still remains the same and dna says here is plenty of money if the science is what you claim it to be. I personally believed some longs seemed to understand the science and wasn`t just pumping the stock, my point is, the sky is the limit, "RIGHT" ? Am I being to optimistic ? PLEASE REPLY
Merry christmas everyone and im sure everything will turn out just fine with I.N.S.M. But it kills me to think they ran it up in the middle of the trial from 1.05 and unloaded on us at 1.90, 1.80, 1.70. And to think I fell for it hook,line and sinker when I could have finally broke even at 1.72. And then had a fresh start by buying in today. That to date is by far my biggest regret of 06` Im just hoping it dosent turn from bad to worse in 07`. Good luck everyone with the same situation. Lets just Hope 07` turns out to be a great year for everyone. Happy holidays, Steve
Thanks again sminvestor
sm investor, how about the other question I had about the possibilty of the company being bought 10,000 shares at a time. As posted.
thanks sminvestor sounds reasonable
also, how true is this, thanks
looks like someone is "buying the company" 10k at a time
10:31:18 10000 0.9502 NASD ADF
10:14:12 10000 0.9411 NASD ADF Q
10:13:18 10000 0.949 NASD ADF Q
10:07:42 10000 0.949 NASD ADF Q
10:06:27 10000 0.95 NASD ADF
10:04:36 10000 0.95 NASD ADF Q
09:54:18 10000 0.95 NASD ADF Q
09:52:33 10000 0.9299 NASD ADF Q
09:49:48 10000 0.93 NASD ADF Q
09:49:48 10000 0.92 NASD ADF Q
09:47:54 10000 0.94 NASD ADF Q
09:44:27 10000 0.97 NASD ADF Q
09:43:33 10000 0.97 NASD ADF Q
09:40:42 10000 0.99 NASD ADF Q
09:39:51 10000 0.9802 NASD ADF Q
09:39:21 10000 0.9802 NASD ADF Q
09:39:21 10000 0.9805 NASD ADF Q
09:38:06 10000 0.99 NASD ADF Q
09:37:36 10000 0.99 NASD
09:35:15 10000 1.01 NASD ADF Q
09:34:45 10000 1.01 NASD ADF Q
09:34:33 10000 1.01 NASD ADF
09:32:36 10000 1.01 NASD ADF Q
09:32:03 10000 1.02 NASD ADF Q
08:16:39 10000 1.00 NASD T (F)
A little help pls, how true is this article ?http://biz.yahoo.com/seekingalpha/061214/22399_id.html?.v=1
SeekingAlpha
Insmed Loses Patent Case to Tercica; Companies Should Merge
Thursday December 14, 2:23 am ET
Andrew Vaino submits: As I mentioned last week in the Daily Blog, the patent case between Insmed (NASDAQ: INSM - News) and Tercica (NASDAQ: TRCA - News) decided in Tercica's favor. A jury found that Insmed infringed on Tercica's patents and ordered them to pay $7.5M in damages.
As well, Insmed was ordered to pay Tercica a 15% royalty on sales of less than $100M and 20% on sales above $100M. Insmed hasn't filed any appeal. I'm very happy I had a stop order for $1.50, and got out with a slight profit. INSM is now trading at less than a dollar.
To recap, both Insmed and Tercica sell insulin-like growth factor-1 [IGF-1] for the treatment of growth deficiencies in children who don't respond to normal human growth hormone therapy. Tercica's drug, Increlex, is given twice a day by injection and Iplex, Insmed's drug, is given once a day. Iplex is cleverly delivered with a complementary binding protein to improve distribution in the body.
Of the two, I think Insmed has the better pipeline. In addition to Iplex to treat growth deficiency, Insmed completed Phase 2 studies looking at application of Iplex to diabetes (in particular extreme insulin resistance), as well as to patients receiving skin grafts. Insmed also has a Phase 1/2 clinical study underway to treat prostate cancer and has a potential treatment for complications arising from HIV. According to the FDA's website, Insmed is not currently pursuing any Phase 3 studies.
Tercica recently licensed Somatuline Autogel to treat patients with acromegaly (a disorder in which the pituitary gland produces too much growth hormone). A NDA had been filed, and Tercica should hear back late next year. This, like Increlex, won't have a huge market but, as I mentioned, that's ok for such a small company.
While Tercica is the stronger company right now, I think the small market size for its products won't provide for much increase in stock price and therefore I wouldn't buy. Indeed, TRCA is up less than 15% since the verdict: this is still preferable to the 50% haircut INSM has taken.
I think Insmed is now is a world of hurt. In a best case scenario sales for Iplex will not be great (likely less than $200M/yr), so losing 15-20% hurts. Also, manufacturing IGF-1 isn't easy or cheap. Last spring INSM took a plunge when their auditors said they weren't certain the company had the ability to continue as a going concern. This report was a bit premature in that it didn't take into account a secondary offering of stock (predicted the week before in the Weekly Newsletter!) into account.
Regardless, at the end of Q3 Insmed has ~$30M net current assets, very weak sales, and no new products on the horizon for years. With a stock price below ninety cents, financing options are limited.
I think Iplex is a better drug than Increlex. My take, as I mentioned previously, is the best thing is for these companies to merge. Given the bad blood between them this won't be easy (the two companies have been almost absurdly litigious) but right now I think Insmed has no choice. So, while I wouldn't buy INSM right now it's worth keeping an eye on. A merger or outright acquisition, which I predict, will send the stock up. It's just a question of finding the bottom.
As a follow-up to my post on Friday about Encysive (NASDAQ: ENCY - News), the spike it received on announcement they were resuming a Phase 2 study on TCB3711 has dissipated (even after a single 'thumbs up' from Cramer on Monday night). My highly speculative short position is still under water, but less worryingly so.
about the proxy voting, how are longs voting, how should i vote, what would help the co. Thanks
sorry gismo, here is the linkhttp://www1.investorvillage.com/smbd.asp?clear=1&mb=235&pt=m
gismo, got it here check it out http://www.investorshub.com/boards/login.asp
Anyone know how accurate these statements are ???????????????????able1
<<You...supplier>> I agree more or less. Although we do not know the reasons why INSM moved production facility to US, it is clear that Avecia is still capable and actually producing for INSM in Europe.
"We have manufactured IPLEX™ at our ITP facility and at Avecia’s site at Billingham, England., IPLEX™ has never been manufactured by Avecia in quantities necessary for commercialization;" page 23, latest 10Q-filing, http://www.secinfo.com/d14D5a.v53sb.htm
"This rise in spending resulted from a broader clinical trials program and an increase in manufacturing activity at our ITP facility and at our contract manufacturer Avecia to produce IPLEX for our clinical trials," page 47, latest 10K-filing, http://www.secinfo.com/d14D5a.v1Ccj.htm
<<Neither party has "control" in the matter of the EU market for Iplex, except that Insmed's marketing application has been validated, whereas Tercica's has not. Sounds like a bit of an advantage for Insmed there.>>
True as for INSM; TRCA is highly likely to get their validation next month, in CHMP-meeting. They just got validated by COMP; need to be taken over by CHMP.
INSM:
COMP for INSM 7/14/06: http://www.emea.europa.eu/pdfs/human/comp/27103206en.pdf
CHMP for INSM 8/4/06: http://www.emea.europa.eu/pdfs/human/press/pr/29618506en.pdf
TRCA:
COMP for TRCA 10/4/06: http://www.emea.europa.eu/pdfs/human/comp/38398906en.pdf
Practically it means that INSM still will have a headstart in EU with 3-4 months in selling IPLEX; if the stockholders of TRCA approve the IPSEN deal and TRCA will get approval to sell in EU around April 2007, the headstart of INSM will disappear fast while IPSEN has a huge distribution channel, which INSM does not have yet!!
With the Ruling in Pre-Trial yesterday, 2 motions denied, TRCA's case has become stronger. The motion to reconsider and TRCA's & INSM's reply to that will NOT be ruled upon within the upcoming 2 months!
The chances that INSM will win this lawsuit has been decreased by yesterday's ruling. Practically it would mean they have to pay a royalty to TRCA...To keep this royalty as small as possible, INSM would rather no have any of EU-sales included in that payment, so would like to produce their EU-sales in EU (avecia).
Taken this into consideration it is now highly likely that TRCA would go after an infringement of the 417 patent in EU and will ask for a injunction in EU; they probably will follow the same strategy in EU as they did in US.
Consequently, INSM's PPS will suffer due to EU-litigation for years.
HOW BIG OF A RISK is it to hold your shares into the trial, are we seeing a pump and dump with the recent high volume. I havent heard anything about why the volume went tru the roof lately ? Has anyone ? Or could this be a sign that the trial will go in our favor and people in the know want in ? Something up and dont tell me its the sky ha ha . I gotta BE honest with you Im alittle nervous holding a small bundle heading into the trial, I like to see a settlement or some type of an agreement before. Your thoughts please.
Wow, I FEEL lucky were not under a buck. I thought by the current 6 month trend we be at seventy cents.
what happen to all the longs, I hope nobody Jumped out any windows. (its only money )
Guys did anyone notice if inst. holdings are down recently ?
I just can`t understand how were at a buck, and you feel ok buying more. There comes a point where you have to say those the street know something we don`t. After all it`s all about money why wouldn`t everyone and there mother jump all over this if it was a gd buy at 2 bucks never mind one ? Im very curious to see the new inst. holdings figures next month. And without any news whats to stop this from hitting 85 cents. I wish you the best buying, but the direction dosen`t lie and 90 % of the recent investors are losing including myself big time. Holidays approaching fast ( july ) ? middle east yeah, but thats an old story, The shorters OK. I`ll wait to buy maybe under a buck at this rate. Gd luck Steve
Hello guys, Who would of ever thought we be at a buck, and now who really knows where the bottom is ? Im just praying one day we will crawl out of this hole. Im even scared to average down for the fourth time fearing someone knows something we don`t explaining all the selling and the current price. I can stomach the highs and lows But I can`t stomach something like going out of business or staying at a buck for ever. I have a small fortune invested and Im sure most here do as well. I scrape up enough to possibly buy one more time but don`t have the guts to pull the trigger, But I wish I could, maybe if we get some news or I start seeing the light at the end of the tunnel or anything positive besides positive speculation on idications. Sorry for venting, Good luck steve
recurveman, I wish the street felt as positive as you. We probably wouldn`t be trading at 1.16.
The only thing that can send this lower would be lower than exspected growth or earnings. And It looks like all the news is out about the lawsuit and I gotta believe for those in the retail community who wanted out got out the last couple of days. SO do we sit here for awhile and dribble lower or higher ? And Why couldnt insm put out the fire and come out with a p.r. right after the ruling. Did they exspect this sell off and kinda look forward to it so some could pick up cheap shares. Who really knows whats going on, Im sure the people in the know seen this coming a yr before it comes . You gotta believe at the offering when the big boys buy in, that a clear vision of the future is seen. Who would invest millions without seeing future hurdles and possible outcomes. "This was all EXSPECTED" And what REALLY surprises me is all the educated posters here not seeing it coming. Didn`t insm say in an p.r. or 8k awhile back that they exspected this ruling and exspected to go to court in november. If so, then why hire a lawyer and run around like your head just got chopped off. We shoulda seen the panic and sell off, how long have we been investing in stocks especially (biotechj) Now, I guess if you have a fortuned invested you might want to project the future possibilities before averaging down here. Lets be negative for one minute, What news is exspected and how will it affect the pps because with lower then exspected growth or earnings there will be nothing holding this baby up and the final nail would be the november trial cost along with its current burn rate to do business won`t bold well for the pps. And the target price constantly being mentioned while the pps falls ? Whats going on here ? No pr`s does the company care ? Will the insiders bring this down to under a buck ? While still proclaiming buy with a target of 3 bucks ? I for one know nothing about court rulings or medicine BUT MY GAMBELING HUNCH tells me to buy here and gamble. But it wouldnt surprise me to see it under a buck with anymore bad news. And if that happens and the company survives the people in the know completly cleaned up. Good luck, because without being in the know its gambeling.
I cant see this going below todays close anymore, especially without bad news. I think Today was a buying day, It looks to me like the final day of EXITING for whoever lost faith and buyers bought up whatever was available. We very well could see 1.30 plus from here on, even without good news.
I gotta say, common sense tells me if todays news was long term bad, we would still be trading at todays low or even under a buck. Im no expert but something tells me there was more buying then selling, the buyers bought every share available right up to 1.41 thats a nice return from todays low. Im kinda guessing, but I think we will hang out between 1.36 to 1.46 for a while ?
Hello, I know this will be the hardest question to answer but does anyone think where heading north " anytime soon". Its seems to be hanging around and trading at 1.53 with alittle kicker within the last 15 minutes to move it to even or in this case green ? There seems to be a pattern, Im glad its better then last months pattern but in all it dosen`t seem fitting.
Can anyone please tell me why we went down a weeks worth in one day with positive news ? And then please give me your best guess on what you think might happen tomorrow (price wise). Thanks in advance, Steve
How about talking about I.N.S.M. do you think we will see a close over two after tomorrows conf.
I hate to jinx the upward trend, but I gotta say I hope this baby flys over 2 and never looks back.
In wednesday paper, Newsday www.newsday.com business section
Merck & co. and novartis AG are aimimg to be the first to market a new class of diabetes drugs designed to use the body`s own mechanisms to control blood sugar, the two pills known as DPP-4 inhibitors. DPP-4 inhibitiors are designed to bolster two hormones released by the gut, GLP-1 and GLP-1 AND GIP, that regulate high glucose. The fda is to decide on the products approval in oct. three to four months before a decision on novartis` Galvus.
I see no mention of INSM being involved with Novartis as some here mentioned ?
Is there a bottom with this stock, I know you call it manipulation ? or shorting ? but does the street know something that the positive posters don`t know ? I never seen a stock with all the so called potential, big june news, new fda approved drug, go straight down everyday without even alittle bounce. What is going on here with this gem, we certainly have alot of positive posting going on, that can`t be the problem. From what I seen and understand OVER THE LAST 3 MONTHS Im not the only bag holder here, but that dosent make me feel any better. Can someone take please take a brake from posting positive stuff for a minute and help figure out why over the last 3 months with all this positive potential it looks like we are going to hell instead of heaven ? Thanks Steve
Thanks, coinstarz for your info. If there is one thing I understand about stocks is that you never know whats going to happen no matter what you hear or read, for the most part. And yes I own a small fortune and Im averaged down to 1.96 and not to happy about it as well. And to make matters worse, I`ll be the first to admitt that im a rookie still after 6 yrs and I should be listening to a friend of our family who`s just called us with a tip that doubled in 3 days. ( I.L.E.) That`s what makes me nuts YOU HAVE TO STAND BY with cash until you get a call and I can`t do that at this point because INSM has all my cash. I don`t want to sound greedy but I like to get my cash back and do what he says for now. My problem is I like to take my own shots and I hate to just sit there doing nothing until the call comes in. Im praying by the end of june I could atleast get back 75 % of what I invested or I`LL have to take a loss right now because 2 more symbols are on the way.
Again thanks, Steve
People, I have to tell you, its a real pleasure to read your post. Im surprised and grateful the nuts from the yahho board don`t post here. And if you don`t mind me asking, what`s your estimate on the pps reaching aleast 1.88 again. I only say 1.88 because I think thats the price of the last offering ? Or could we be in trouble law suit wise and earnings wise and have to wait a yr to see any gain at this point? Thanks in advance
Steve